{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:33:20Z","timestamp":1793568800153,"version":"4.5.0"},"reference-count":391,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"St. Boniface Hospital Research Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>With cardiovascular disease (CVD) being a primary source of global morbidity and mortality, it is crucial that we understand the molecular pathophysiological mechanisms at play. Recently, numerous pro-inflammatory cytokines have been linked to several different CVDs, which are now often considered an adversely pro-inflammatory state. These cytokines most notably include interleukin-6 (IL-6),tumor necrosis factor (TNF)\u03b1, and the interleukin-1 (IL-1) family, amongst others. Not only does inflammation have intricate and complex interactions with pathophysiological processes such as oxidative stress and calcium mishandling, but it also plays a role in the balance between tissue repair and destruction. In this regard, pre-clinical and clinical evidence has clearly demonstrated the involvement and dynamic nature of pro-inflammatory cytokines in many heart conditions; however, the clinical utility of the findings so far remains unclear. Whether these cytokines can serve as markers or risk predictors of disease states or act as potential therapeutic targets, further extensive research is needed to fully understand the complex network of interactions that these molecules encompass in the context of heart disease. This review will highlight the significant advances in our understanding of the contributions of pro-inflammatory cytokines in CVDs, including ischemic heart disease (atherosclerosis, thrombosis, acute myocardial infarction, and ischemia-reperfusion injury), cardiac remodeling (hypertension, cardiac hypertrophy, cardiac fibrosis, cardiac apoptosis, and heart failure), different cardiomyopathies as well as ventricular arrhythmias and atrial fibrillation. In addition, this article is focused on discussing the shortcomings in both pathological and therapeutic aspects of pro-inflammatory cytokines in CVD that still need to be addressed by future studies.<\/jats:p>","DOI":"10.3390\/ijms25021082","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:03:30Z","timestamp":1705377810000},"page":"1082","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":396,"title":["The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease"],"prefix":"10.3390","volume":"25","author":[{"given":"Hannah","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada"},{"name":"Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naranjan S.","family":"Dhalla","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada"},{"name":"Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"ref_1","unstructured":"(2023, February 09). Cardiovascular Diseases (CVDs). Available online: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_2","unstructured":"(2023, February 09). Cardiovascular Disease Burden. Available online: https:\/\/www.paho.org\/en\/enlace\/cardiovascular-disease-burden."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCULATIONAHA.120.053216","article-title":"Spending on cardiovascular disease and cardiovascular risk factors in the United States: 1996 to 2016","volume":"144","author":"Birger","year":"2021","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Floege, J., L\u00fcscher, B., and M\u00fcller-Newen, G. (2012). Cytokines and inflammation. Eur. J. Cell Biol., 91.","DOI":"10.1016\/j.ejcb.2012.01.003"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"2. Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J. Allergy Clin. Immun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/imr.12671","article-title":"Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology","volume":"285","author":"Cicchese","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1071-9164(96)80047-9","article-title":"Basic mechanisms in heart failure: The cytokine hypothesis","volume":"2","author":"Seta","year":"1996","journal-title":"J. Card. Fail."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2050312120965752","DOI":"10.1177\/2050312120965752","article-title":"Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer","volume":"8","author":"Amin","year":"2020","journal-title":"Sage Open Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.CIR.0000060808.79274.0C","article-title":"Proinflammatory cytokines","volume":"107","author":"Murray","year":"2003","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0733-8651(05)70041-2","article-title":"The role of cytokines in the failing human heart","volume":"16","author":"Kapadia","year":"1998","journal-title":"Cardiol. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/eurheartj\/ehq484","article-title":"When are pro-inflammatory cytokines SAFE in heart failure?","volume":"32","author":"Lecour","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000046960","article-title":"Proinflammatory cytokines in heart disease","volume":"19","author":"Dinarello","year":"2001","journal-title":"Blood Purif."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/07853890510007232","article-title":"Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications","volume":"37","author":"Aukrust","year":"2005","journal-title":"Ann. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart","volume":"116","author":"Mann","year":"2015","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy biological basis of CANTOS and beyond","volume":"70","author":"Libby","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.108.772491","article-title":"Inflammation and cardiovascular disease","volume":"117","author":"Fearon","year":"2008","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","article-title":"The role of the tgf-\u03b2 superfamily in myocardial infarction","volume":"6","author":"Hanna","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-\u03b2, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cytogfr.2018.08.003","article-title":"Cytokines as therapeutic agents and targets in heart disease","volume":"43","author":"Dubnika","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.RES.0000150734.79804.92","article-title":"Cytokine-induced modulation of cardiac function","volume":"95","author":"Prabhu","year":"2004","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ajpath.2020.05.007","article-title":"The surprising story of IL-2 from experimental models to clinical application","volume":"190","author":"Abbas","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","article-title":"Effects of interleukin 17 on the cardiovascular system","volume":"16","author":"Robert","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cytogfr.2010.10.003","article-title":"Interleukin 17 in vascular inflammation","volume":"21","author":"Ley","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fphar.2020.00129","article-title":"Roles and mechanisms of Interleukin-12 family members in cardiovascular diseases: Opportunities and challenges","volume":"11","author":"Ye","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/01.CIR.0000070542.18001.87","article-title":"Interleukin-7\u2013mediated inflammation in unstable angina","volume":"107","author":"Yndestad","year":"2003","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/apm.12246","article-title":"Effect of serum interleukin 21 on the development of coronary artery disease","volume":"122","author":"Ding","year":"2014","journal-title":"APMIS"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","article-title":"Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets","volume":"26","author":"Ramji","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 Signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/01.ATV.19.7.1623","article-title":"Angiotensin induces inflammatory activation of human vascular smooth muscle cells","volume":"19","author":"Schmidt","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_33","first-page":"F1000 Faculty Rev-1013","article-title":"Interleukin-6 signalling in health and disease","volume":"9","year":"2020","journal-title":"F1000Research"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6","volume":"8","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","article-title":"Rethinking IL-6 and CRP: Why the are more than inflammatory biomarkers, and why it matters","volume":"70","author":"Giudice","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/phrs.1998.0463","article-title":"The role of TNF in cardiovascular disease","volume":"40","author":"Ferrari","year":"1999","journal-title":"Pharmacol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1011449708842","article-title":"Recent insights into the role of tumor necrosis factor in the failing heart","volume":"6","author":"Mann","year":"2001","journal-title":"Heart Fail. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00132580-200109000-00008","article-title":"The role of tumor necrosis factor in cardiac disease","volume":"3","author":"Retter","year":"2001","journal-title":"Heart Dis."},{"key":"ref_39","unstructured":"Dziubla, T., and Butterfield, D.A. (2016). Oxidative Stress and Biomaterials, Academic Press."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"695047","DOI":"10.3389\/fphys.2021.695047","article-title":"Inflammatory cytokines, immune cells, and organ interactions in heart failure","volume":"12","author":"Li","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9149(90)90291-8","article-title":"Detection and localization of tumor necrosis factor in human atheroma","volume":"65","author":"Barath","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 Family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40119-018-0104-3","article-title":"A Review of Interleukin-1 in Heart Disease: Where do we stand today?","volume":"7","author":"Szekely","year":"2018","journal-title":"Cardiol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11897-014-0231-7","article-title":"Targeting interleukin-1 in heart failure and inflammatory heart disease","volume":"12","author":"Tassell","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/CRD.0000000000000022","article-title":"Interleukin 1beta: A proinflammatory target for preventing atherosclerotic heart disease","volume":"22","author":"McCarty","year":"2014","journal-title":"Cardiol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00011-020-01382-6","article-title":"The role of interferon-\u03b3 in cardiovascular disease: An Update","volume":"69","author":"Elyasi","year":"2020","journal-title":"Inflamm. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/iai.57.2.590-595.1989","article-title":"Endotoxin-induced serum factor that stimulates gamma interferon production","volume":"57","author":"Nakamura","year":"1989","journal-title":"Infect. Immun."},{"key":"ref_50","first-page":"884","article-title":"Interleukin-18 (IL-18) synergizes with il-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells","volume":"61","author":"Son","year":"2001","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-\u03b2: A master of all T cell trades","volume":"134","author":"Li","year":"2008","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1573403X14666181031115118","article-title":"Application of G-CSF in congestive heart failure treatment","volume":"15","author":"Pourtaji","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1084\/jem.20170689","article-title":"The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes","volume":"214","author":"Anzai","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_55","first-page":"11","article-title":"Managing toxicities of high-dose interleukin-2","volume":"16","author":"Schwartz","year":"2002","journal-title":"Oncology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e022452","DOI":"10.1136\/bmjopen-2018-022452","article-title":"Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): Protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I\/II clinical trial","volume":"8","author":"Zhao","year":"2018","journal-title":"BMJ Open"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: The yin and the yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"108191","DOI":"10.1016\/j.pharmthera.2022.108191","article-title":"The IL-18\/IL-18R1 signalling axis: Diagnostic and therapeutic potential in hypertension and chronic kidney disease","volume":"239","author":"Thomas","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Shah, A.K., Bhullar, S.K., Elimban, V., and Dhalla, N.S. (2021). Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure. Antioxidants, 10.","DOI":"10.3390\/antiox10060931"},{"key":"ref_61","first-page":"1","article-title":"Role of intracellular Ca2+-overload in cardiac dysfunction in heart disease","volume":"3","author":"Nusier","year":"2020","journal-title":"Clin. Cardiol. Cardiovasc. Interv."},{"key":"ref_62","first-page":"213","article-title":"Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart","volume":"10","author":"Saini","year":"2005","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","article-title":"Role of oxidative stress in cardiovascular diseases","volume":"18","author":"Dhalla","year":"2000","journal-title":"J. Hypertens."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Dhalla, N.S., Shah, A.K., and Tappia, P.S. (2020). Role of oxidative stress in metabolic and subcellular abnormalities in diabetic cardiomyopathy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072413"},{"key":"ref_66","first-page":"587","article-title":"Evidence for the role of oxidative stress in acute ischemic heart disease: A brief review","volume":"15","author":"Dhalla","year":"1999","journal-title":"Can. J. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0008-6363(00)00078-X","article-title":"Status of myocardial antioxidants in ischemia\u2013reperfusion injury","volume":"47","author":"Dhalla","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.ph.52.030190.002551","article-title":"Mechanisms of Ca2+ overload in reperfused ischemic myocardium","volume":"52","author":"Tani","year":"1990","journal-title":"Annu. Rev. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2004.11.131","article-title":"TNF-\u03b1 as a potential mediator of cardiac dysfunction due to intracellular Ca2+-overload. Biochem","volume":"327","author":"Zhang","year":"2005","journal-title":"Biophys. Res. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.RES.63.2.313","article-title":"Defects in sarcolemmal Ca2+ transport in hearts due to induction of calcium paradox","volume":"63","author":"Makino","year":"2018","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.RES.48.1.17","article-title":"Role of changes in microsomal calcium uptake in the effects of reperfusion of Ca2+-deprived rat hearts","volume":"48","author":"Alto","year":"2018","journal-title":"Circ. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7092151","DOI":"10.1155\/2019\/7092151","article-title":"Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease","volume":"2019","author":"Steven","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7432797","DOI":"10.1155\/2016\/7432797","article-title":"Oxidative stress and inflammation: What polyphenols can do for us?","volume":"2016","author":"Hussain","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: How are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.87.6.1806","article-title":"Intracellular calcium homeostasis in cardiac myocytes","volume":"87","author":"Barry","year":"2018","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jim-2020-001754","article-title":"Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?","volume":"69","author":"Adamyan","year":"2021","journal-title":"J. Investig. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Severino, P., D\u2019Amato, A., Pucci, M., Infusino, F., Adamo, F., Birtolo, L.I., Netti, L., Montefusco, G., Chimenti, C., and Lavalle, C. (2020). Ischemic heart disease pathophysiology paradigms overview: From plaque activation to microvascular dysfunction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218118"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/1043-4666(94)90013-2","article-title":"Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions","volume":"6","author":"Seino","year":"1994","journal-title":"Cytokine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.4049\/jimmunol.146.11.3799","article-title":"Release of the cytokines colony-stimulating factor-1, granulocyte-macrophage colony-stimulating factor, and IL-6 by cloned murine vascular smooth muscle cells","volume":"146","author":"Schrader","year":"1991","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice","volume":"19","author":"Huber","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01606532","article-title":"Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of Cell-Mediated Immunity in Human Atherogenesis","volume":"423","author":"Kishikawa","year":"1993","journal-title":"Virchows Arch. A"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/01.ATV.18.9.1498","article-title":"Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice","volume":"18","author":"Sukovich","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(96)05968-0","article-title":"Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall","volume":"127","author":"Rus","year":"1996","journal-title":"Atherosclerosis"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(00)00682-1","article-title":"Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17\u03b2-estradiol in apolipoprotein E-deficient mice","volume":"156","author":"Elhage","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and c-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","article-title":"Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy","volume":"286","author":"Lindmark","year":"2001","journal-title":"JAMA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00592-010-0198-0","article-title":"The predictive value of TNF-\u03b1 and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes","volume":"49","author":"Wu","year":"2012","journal-title":"Acta Diabetol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"155443","DOI":"10.1016\/j.cyto.2021.155443","article-title":"Klotho, FOXO1 and cytokines associations in patients with coronary artery disease","volume":"141","author":"Fard","year":"2021","journal-title":"Cytokine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","article-title":"Elevated levels of interleukin-6 in unstable angina","volume":"94","author":"Biasucci","year":"1996","journal-title":"Circulation"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00019501-199703000-00004","article-title":"Altered plasma levels of cytokines in patients with ischemic heart disease","volume":"8","author":"Tashiro","year":"1997","journal-title":"Coron. Artery Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2003.08.002","article-title":"endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy","volume":"94","author":"Tentolouris","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","article-title":"Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2004.08.073","article-title":"Exercise training modulates cytokines activity in coronary heart disease patients","volume":"100","author":"Goldhammer","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1074\/jbc.M111727200","article-title":"Loss of lymphotoxin-\u03b1 but not tumor necrosis factor-\u03b1 reduces atherosclerosis in mice","volume":"277","author":"Schreyer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0021-9150(91)90066-C","article-title":"Tumor Necrosis factor-alpha in human arterial wall with atherosclerosis","volume":"89","author":"Rus","year":"1991","journal-title":"Atherosclerosis"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"B36","DOI":"10.1016\/0002-9149(91)90383-V","article-title":"Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: A morphologic, immunohistochemical, and biochemical study","volume":"68","author":"Arbustini","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00024382-200202000-00006","article-title":"Ischemia alone is sufficient to induce TNF-\u03b1 mrna and peptide in the myocardium","volume":"17","author":"Shames","year":"2002","journal-title":"Shock"},{"key":"ref_100","first-page":"1721","article-title":"Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques","volume":"142","author":"Tipping","year":"1993","journal-title":"Am. J. Pathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.ATV.17.5.963","article-title":"Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism","volume":"17","author":"Huang","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_102","first-page":"301","article-title":"Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis","volume":"140","author":"Clinton","year":"1992","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"26174","DOI":"10.1074\/jbc.271.42.26174","article-title":"Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55","volume":"271","author":"Schreyer","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/euhj.2001.2805","article-title":"Plasma tumour necrosis factor-\u03b1 and early carotid atherosclerosis in healthy middle-aged men","volume":"23","author":"Skoog","year":"2002","journal-title":"Eur. Heart J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1084\/jem.165.5.1316","article-title":"Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells","volume":"165","author":"Warner","year":"1987","journal-title":"J. Exp. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1172\/JCI112732","article-title":"Inducible interleukin-1 gene expression in human vascular smooth muscle cells","volume":"78","author":"Libby","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_107","first-page":"179","article-title":"Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells","volume":"124","author":"Libby","year":"1986","journal-title":"Am. J. Pathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","article-title":"Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E\u2013deficient mice","volume":"97","author":"Elhage","year":"1998","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","article-title":"Interleukin-1 Plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice","volume":"66","author":"Kwak","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1073\/pnas.092324399","article-title":"Genetic Alterations of IL-1 Receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size","volume":"99","author":"Devlin","year":"2002","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1\u03b2 decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI118476","article-title":"Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor","volume":"97","author":"Shimokawa","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00019501-200111000-00007","article-title":"Elevated interleukin-1\u03b2 in pericardial fluid of patients with ischemic heart disease","volume":"12","author":"Oyama","year":"2001","journal-title":"Coron. Artery Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: Rationale and design of the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of interleukin-1\u03b2 and reduction in atherothrombotic cardiovascular events in the CANTOS trial","volume":"76","author":"Everett","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.ATV.13.2.197","article-title":"An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium","volume":"13","author":"Li","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1172\/JCI117628","article-title":"Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines","volume":"95","author":"Li","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1016\/S0021-9258(19)38462-5","article-title":"Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma","volume":"265","author":"Fong","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.170.5.1595","article-title":"Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells","volume":"170","author":"Hansson","year":"1989","journal-title":"J. Exp. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in apoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_122","first-page":"454","article-title":"Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"Buono","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol. J. Am. Heart Assoc."},{"key":"ref_123","first-page":"169","article-title":"Detection of activated T lymphocytes in the human atherosclerotic plaque","volume":"135","author":"Hansson","year":"1989","journal-title":"Am. J. Pathol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Ulfgren","year":"1999","journal-title":"Atherosclerosis"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three t lymphocyte-activating cxc chemokines by human atheroma-associated cells","volume":"104","author":"Mach","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.CIR.100.21.2135","article-title":"Perturbation of the t-cell repertoire in patients with unstable angina","volume":"100","author":"Liuzzo","year":"1999","journal-title":"Circulation"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","article-title":"Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice","volume":"59","author":"Elhage","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.ATV.0000168417.52486.56","article-title":"Associations of serum IL-18 levels with carotid intima-media thickness","volume":"25","author":"Yamagami","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000099509.76044.A2","article-title":"Interleukin-18 and the risk of coronary heart disease in European men","volume":"108","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina","volume":"106","author":"Blankenberg","year":"2002","journal-title":"Circulation"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.16.8.1007","article-title":"Interleukin-8 Production by macrophages from atheromatous plaques","volume":"16","author":"Apostolopoulos","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1074\/jbc.271.15.8837","article-title":"Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma","volume":"271","author":"Wang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.ATV.0000134294.54422.2e","article-title":"IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women","volume":"24","author":"Boekholdt","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1365-2362.2002.01053.x","article-title":"Selectin-P and interleukin-8 plasma levels in coronary heart disease patients","volume":"32","author":"Romuk","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000331970405500308","article-title":"Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in Apo-E-deficient mice","volume":"55","author":"Upadhya","year":"2004","journal-title":"Angiology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/clc.4960240315","article-title":"Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease","volume":"24","author":"Simon","year":"2001","journal-title":"Clin. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.CIR.103.4.549","article-title":"Interleukin-3 stimulates migration and proliferation of vascular smooth muscle cells","volume":"103","author":"Brizzi","year":"2001","journal-title":"Circulation"},{"key":"ref_139","first-page":"922","article-title":"Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor","volume":"88","author":"Jansen","year":"1996","journal-title":"Blood"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2230.1996.tb00007.x","article-title":"Endothelial cell activation in cutaneous vasculitis","volume":"21","author":"Jurd","year":"1996","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2003.11.062","article-title":"Relationship of interleukin-6 and c-reactive protein to the prothrombotic state in chronic atrial fibrillation","volume":"43","author":"Conway","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"H250","DOI":"10.1152\/ajpheart.1998.275.1.H250","article-title":"cytokine expression increases in nonmyocytes from rats with postinfarction heart failure","volume":"275","author":"Yue","year":"1998","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.115.016160","article-title":"Targeting interleukin-1\u03b2 reduces leukocyte production after acute myocardial infarction","volume":"132","author":"Sager","year":"2015","journal-title":"Circulation"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2006.02.034","article-title":"Cytokine profiles and t cell function in acute coronary syndromes","volume":"190","author":"Steppich","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.98.7.699","article-title":"Resident cardiac mast cells degranulate and release preformed TNF-\u03b1, initiating the cytokine cascade in experimental canine myocardial ischemia\/reperfusion","volume":"98","author":"Frangogiannis","year":"1998","journal-title":"Circulation"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"White, D.A., Fang, L., Chan, W., Morand, E.F., Kiriazis, H., Duffy, S.J., Taylor, A.J., Dart, A.M., Du, X.-J., and Gao, X.-M. (2013). Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells. PLoS ONE, 8.","DOI":"10.1371\/annotation\/6e24b7bb-83c7-4887-9621-96b64acfb1c1"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/cc11467","article-title":"Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction","volume":"16","author":"Becher","year":"2012","journal-title":"Crit. Care"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2796.2012.02517.x","article-title":"Increased interleukin-1\u03b2 levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention","volume":"272","author":"Ueland","year":"2012","journal-title":"J. Intern. Med."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Zhao, J., Lau, W.B., Jiao, L.-Y., Liu, B., Yuan, Y., Wang, X., Gao, E., Koch, W.J., and Ma, X.-L. (2013). Tumor necrosis factor-\u03b1 and lymphotoxin-\u03b1 mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060227"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.99.11.1492","article-title":"Tissue expression and immunolocalization of tumor necrosis factor-\u03b1 in postinfarction dysfunctional myocardium","volume":"99","author":"Irwin","year":"1999","journal-title":"Circulation"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-\u03b1 and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","article-title":"Tumor necrosis factor-\u03b1 receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction","volume":"111","author":"Valgimigli","year":"2005","journal-title":"Circulation"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"837642","DOI":"10.3389\/fimmu.2022.837642","article-title":"Circulating cytokines in myocardial infarction are associated with coronary blood flow","volume":"13","author":"Kalinskaya","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e25553","DOI":"10.1097\/MD.0000000000025553","article-title":"Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods","volume":"100","author":"Guo","year":"2021","journal-title":"Medicine"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/heartjnl-2013-303648","article-title":"Cardiovascular effects of tumour necrosis factor \u03b1 antagonism in patients with acute myocardial infarction: A first in human study","volume":"99","author":"Padfield","year":"2013","journal-title":"Heart"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40268-013-0025-5","article-title":"N-acetylcysteine effects on transforming growth factor-\u03b2 and tumor necrosis factor-\u03b1 serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction","volume":"13","author":"Talasaz","year":"2013","journal-title":"Drugs R D"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1161\/01.CIR.0000016602.96363.36","article-title":"Fundamentals of reperfusion injury for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.CIR.0000055318.09997.1F","article-title":"Oxidative stress mediates tumor necrosis factor-\u03b1\u2013induced mitochondrial DNA damage and dysfunction in cardiac myocytes","volume":"107","author":"Suematsu","year":"2003","journal-title":"Circulation"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0735-1097(96)00105-2","article-title":"Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion","volume":"28","author":"Gurevitch","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0003-4975(97)01297-6","article-title":"Increased myocardial tumor necrosis factor-\u03b1 in a crystalloid-perfused model of cardiac ischemia-reperfusion injury","volume":"65","author":"Meldrum","year":"1998","journal-title":"Ann. Thorac. Surg."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"H1914","DOI":"10.1152\/ajpheart.1998.274.6.H1914","article-title":"Microvascular transport is associated with tnf plasma levels and protein synthesis in postischemic muscle","volume":"274","author":"Takenaka","year":"1998","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0735-1097(02)01738-2","article-title":"Improved myocardial ischemia\/reperfusion injury in mice lacking tumor necrosis factor-\u03b1","volume":"39","author":"Maekawa","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/ATVBAHA.107.142521","article-title":"TNF-\u03b1 contributes to endothelial dysfunction by upregulating arginase in ischemia\/reperfusion injury","volume":"27","author":"Gao","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2015.02.002","article-title":"TNF-\u03b1 inhibitor protects against myocardial ischemia\/reperfusion injury via notch1-mediated suppression of oxidative\/nitrative stress","volume":"82","author":"Pei","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"H2242","DOI":"10.1152\/ajpheart.00587.2008","article-title":"Role of TNF-\u03b1-induced reactive oxygen species in endothelial dysfunction during reperfusion injury","volume":"295","author":"Gao","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0735-1097(97)00328-8","article-title":"Anti\u2013tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion","volume":"30","author":"Gurevitch","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.fjc.0000250079.46526.38","article-title":"Inhibition of TNF-\u03b1 reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog","volume":"48","author":"Gu","year":"2006","journal-title":"J. Cardiovasc. Pharm."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1142\/S0192415X13500845","article-title":"Cardioprotection of vitexin on myocardial ischemia\/reperfusion injury in rat via regulating inflammatory cytokines and MAPK pathway","volume":"41","author":"Dong","year":"2013","journal-title":"Am. J. Chin. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/jsre.1998.5304","article-title":"Adenosine reduces cardiac TNF-\u03b1 production and human myocardial injury following ischemia-reperfusion","volume":"76","author":"Cain","year":"1998","journal-title":"J. Surg. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cardiores.2004.10.003","article-title":"Free radicals trigger TNF\u03b1-induced cardioprotection","volume":"65","author":"Lecour","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1084\/jem.189.11.1699","article-title":"Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation","volume":"189","author":"Yamashita","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1152\/japplphysiol.00671.2016","article-title":"Myocardial ischemic tolerance in rats subjected to endurance exercise training during adaptation to chronic hypoxia","volume":"122","year":"2017","journal-title":"J. Appl. Physiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00011-016-0931-4","article-title":"Reduced acute myocardial ischemia\u2013reperfusion injury in IL-6-deficient mice employing a closed-chest model","volume":"65","author":"Jong","year":"2016","journal-title":"Inflamm. Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.18632\/aging.202276","article-title":"Hypoxia-inducible factor 2-alpha-dependent induction of IL-6 protects the heart from ischemia\/reperfusion injury","volume":"13","author":"Wu","year":"2021","journal-title":"Aging"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"9743280","DOI":"10.1155\/2017\/9743280","article-title":"NLRP3 Inflammasome activation-mediated pyroptosis aggravates myocardial ischemia\/reperfusion injury in diabetic rats","volume":"2017","author":"Qiu","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/FJC.0000000000000452","article-title":"Reduction of myocardial ischemia\u2013reperfusion injury by inhibiting interleukin-1 alpha","volume":"69","author":"Mauro","year":"2017","journal-title":"J. Cardiovasc. Pharm."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"110141","DOI":"10.1016\/j.cellsig.2021.110141","article-title":"Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia\/reperfusion injury by transcriptional activation of CXCL16","volume":"87","author":"Zhao","year":"2021","journal-title":"Cell. Signal."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1073\/pnas.041611398","article-title":"Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1\u03b2","volume":"98","author":"Pomerantz","year":"2001","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_181","first-page":"e155236","article-title":"Targeting IL-36 improves age-related coronary microcirculatory dysfunction and attenuates myocardial ischaemia-reperfusion injury in mice","volume":"7","author":"Kavanagh","year":"2022","journal-title":"J. Clin. Investig. Insight"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","article-title":"Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration","volume":"59","author":"Liao","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/tri.12349","article-title":"Necrostatin-1 inhibits Hmgb1-IL-23\/IL-17 pathway and attenuates cardiac ischemia reperfusion injury","volume":"27","author":"Zhang","year":"2014","journal-title":"Transplant. Int."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41419-022-04533-1","article-title":"Cardiomyocyte IL-1R2 protects heart from ischemia\/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis","volume":"13","author":"Lin","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cpcardiol.2007.01.002","article-title":"Systemic hypertension","volume":"32","author":"Elliott","year":"2007","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14779072.2018.1540301","article-title":"Pathophysiology of essential hypertension: An update","volume":"16","author":"Saxena","year":"2018","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1172\/JCI74084","article-title":"DC Isoketal-modified proteins activate T cells and promote hypertension","volume":"124","author":"Kirabo","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/cvr\/cvy112","article-title":"Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: Roles of STAT3, interleukin 6 and hydrogen peroxide","volume":"114","author":"Loperena","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.RES.84.6.695","article-title":"Angiotensin II Induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-\u039aB transcription factors","volume":"84","author":"Han","year":"1999","journal-title":"Circ. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1096\/fasebj.14.9.1093","article-title":"Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells","volume":"14","author":"Gornikiewicz","year":"2000","journal-title":"FASEB J."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"R590","DOI":"10.1152\/ajpregu.00207.2009","article-title":"Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells","volume":"299","author":"Li","year":"2010","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"H935","DOI":"10.1152\/ajpheart.00708.2005","article-title":"Angiotensin II Hypertension is attenuated in interleukin-6 knockout mice","volume":"290","author":"Lee","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2353\/ajpath.2007.061078","article-title":"Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo","volume":"171","author":"Coles","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor\u2013dependent mechanism","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.38.3.399","article-title":"Blood pressure and inflammation in apparently healthy men","volume":"38","author":"Chae","year":"2001","journal-title":"Hypertension"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.jhh.1001845","article-title":"Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects","volume":"19","author":"Zamora","year":"2005","journal-title":"J. Hum. Hypertens."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00004872-199715120-00016","article-title":"Tumor necrosis factor-\u03b1-angiotensin interactions and regulation of blood pressure","volume":"15","author":"Ferreri","year":"1997","journal-title":"J. Hypertens."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"F148","DOI":"10.1152\/ajprenal.1998.274.1.F148","article-title":"Angiotensin II induces TNF production by the thick ascending limb: Functional implications","volume":"274","author":"Ferreri","year":"1998","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.107.102152","article-title":"Involvement of tumor necrosis factor-\u03b1 in angiotensin II\u2013mediated effects on salt appetite, hypertension, and cardiac hypertrophy","volume":"51","author":"Sriramula","year":"2008","journal-title":"Hypertension"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"3080863","DOI":"10.1155\/2021\/3080863","article-title":"Lifestyle-Induced redox-sensitive alterations: Cross-talk among the RAAS, antioxidant\/inflammatory status, and hypertension","volume":"2021","author":"Hoffmann","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II\u2013induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11010-009-0136-z","article-title":"Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats","volume":"330","author":"Tran","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/HYPERTENSIONAHA.110.157685","article-title":"Tumor necrosis factor-\u03b1 antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus","volume":"56","author":"Manigrasso","year":"2010","journal-title":"Hypertension"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/01.HYP.0000198545.01860.90","article-title":"Tumor necrosis factor \u03b1 blockade increases renal cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension","volume":"47","author":"Elmarakby","year":"2006","journal-title":"Hypertension"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1152\/ajpregu.00466.2007","article-title":"TNF-\u03b1 inhibition reduces renal injury in DOCA-salt hypertensive rats","volume":"294","author":"Elmarakby","year":"2008","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Snyder, E.C., Abdelbary, M., El-Marakby, A., and Sullivan, J.C. (2022). Treatment of male and female spontaneously hypertensive rats with TNF-\u03b1 inhibitor etanercept increases markers of renal injury independent of an effect on blood pressure. Biol. Sex. Differ., 13.","DOI":"10.1186\/s13293-022-00424-4"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/HYPERTENSIONAHA.114.03863","article-title":"Tumor necrosis factor-\u03b1 produced in the kidney contributes to angiotensin II\u2013dependent hypertension","volume":"64","author":"Zhang","year":"2018","journal-title":"Hypertension"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"21960","DOI":"10.1038\/srep21960","article-title":"Renal tumor necrosis factor \u03b1 contributes to hypertension in Dahl salt-sensitive rats","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Sriramula, S., Cardinale, J.P., and Francis, J. (2013). Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063847"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.taap.2014.09.004","article-title":"Inhibition of TNF-\u03b1 in hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by inhibiting neurohormonal excitation in spontaneously hypertensive rats","volume":"281","author":"Song","year":"2014","journal-title":"Toxicol. Appl. Pharm."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1440-1681.2001.03429.x","article-title":"Association of serum tumour necrosis factor-\u03b1 with serum low-density lipoprotein\u2013cholesterol and blood pressure in apparently healthy Japanese women","volume":"28","author":"Ito","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_212","first-page":"272","article-title":"Circulating tumor necrosis factor-\u03b1 concentrations in a native Canadian population with high rates of type 2 diabetes mellitus","volume":"84","author":"Zinman","year":"1999","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1039\/C9FO03085A","article-title":"Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: Results from a randomized controlled trial","volume":"11","author":"Yang","year":"2020","journal-title":"Food Funct."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/01.HYP.19.6.804","article-title":"Interferon gamma attenuates hypertensive renal injury in salt-sensitive dahl rats","volume":"19","author":"Ishimitsu","year":"2018","journal-title":"Hypertension"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI76327","article-title":"Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation","volume":"125","author":"Saleh","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/HYPERTENSIONAHA.114.04975","article-title":"Renal transporter activation during angiotensin-II hypertension is blunted in interferon-\u03b3\u2212\/\u2212 and interleukin-17a\u2212\/\u2212 mice","volume":"65","author":"Kamat","year":"2018","journal-title":"Hypertension"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCRESAHA.116.310480","article-title":"T-cell mineralocorticoid receptor controls blood pressure by regulating interferon-gamma","volume":"120","author":"Sun","year":"2017","journal-title":"Circ. Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.celrep.2017.10.002","article-title":"Dendritic cell amiloride-sensitive channels mediate sodium-induced inflammation and hypertension","volume":"21","author":"Barbaro","year":"2017","journal-title":"Cell Rep."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.113.00689","article-title":"Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension","volume":"62","author":"Youn","year":"2018","journal-title":"Hypertension"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1096\/fj.11-195198","article-title":"Interferon-\u03b3 biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells","volume":"26","author":"Satou","year":"2012","journal-title":"FASEB J."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","article-title":"Activation of human T cells in hypertension","volume":"68","author":"Itani","year":"2018","journal-title":"Hypertension"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/cvr\/cvaa207","article-title":"Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation","volume":"117","author":"Barbaro","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes rho-kinase-mediated endothelial dysfunction and hypertension","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/CS20190682","article-title":"Interleukin-17A induces vascular remodeling of small arteries and blood pressure elevation","volume":"134","author":"Orejudo","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCRESAHA.114.302157","article-title":"Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase","volume":"114","author":"Wu","year":"2014","journal-title":"Circ. Res."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin ii\u2013induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.116.07493","article-title":"Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin II\u2013induced hypertension","volume":"68","author":"Norlander","year":"2018","journal-title":"Hypertension"},{"key":"ref_228","first-page":"e129278","article-title":"Critical role of interleukin 21 and T follicular helper cells in hypertension and vascular dysfunction","volume":"4","author":"Dale","year":"2019","journal-title":"J. Clin. Investig. Insight"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.122.320818","article-title":"DC ENaC-dependent inflammasome activation contributes to salt-sensitive hypertension","volume":"131","author":"Pitzer","year":"2022","journal-title":"Circ. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.vph.2007.05.007","article-title":"Interleukin 1-beta (IL-1\u03b2) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, rats","volume":"47","author":"Dorrance","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0022-2143(97)90178-5","article-title":"Increased serum levels of interleukin-1\u03b2 in the systemic circulation of patients with essential hypertension: Additional risk factor for atherogenesis in hypertensive patients?","volume":"129","author":"Dalekos","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2362.2001.00743.x","article-title":"Pro-inflammatory cytokines in patients with essential hypertension","volume":"31","author":"Peeters","year":"2001","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Melton, E., and Qiu, H. (2021). Interleukin-1\u03b2 in multifactorial hypertension: Inflammation, vascular smooth muscle cell and extracellular matrix remodeling, and non-coding RNA regulation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168639"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.119.13982","article-title":"IL (Interleukin)-1 receptor antagonist increases ang (angiotensin [1\u20137]) and decreases blood pressure in obese individuals","volume":"75","author":"Urwyler","year":"2020","journal-title":"Hypertension"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","article-title":"Effects of interleukin-1\u03b2 inhibition on blood pressure, incident hypertension, and residual inflammatory risk","volume":"75","author":"Rothman","year":"2019","journal-title":"Hypertension"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-2006-949122","article-title":"IL-18: Relationship with anthropometry, body composition parameters, leptin and arterial hypertension","volume":"38","author":"Vilarrasa","year":"2006","journal-title":"Horm. Metab. Res."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-07-0463","article-title":"The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease","volume":"157","author":"Evans","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"McKie, E.A., Reid, J.L., Mistry, P.C., DeWall, S.L., Abberley, L., Ambery, P.D., and Gil-Extremera, B. (2016). A study to investigate the efficacy and safety of an anti-interleukin-18 monoclonal antibody in the treatment of type 2 diabetes mellitus. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150018"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/HYPERTENSIONAHA.118.12267","article-title":"HIMF (hypoxia-induced mitogenic factor)-IL (interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis","volume":"73","author":"Kumar","year":"2019","journal-title":"Hypertension"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1073\/pnas.92.11.4862","article-title":"Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice","volume":"92","author":"Hirota","year":"1995","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_241","first-page":"570","article-title":"Different expressions of inflammatory cytokines in two types of cardiac hypertrophy in rats","volume":"39","author":"Zhang","year":"2007","journal-title":"J. Peking Univ. Health Sci."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1096\/fj.201701455RR","article-title":"Cardiac fibroblast-specific p38\u03b1 map kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism","volume":"32","author":"Bageghni","year":"2018","journal-title":"FASEB J."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3389\/fimmu.2020.01910","article-title":"Heme induces IL-6 and cardiac hypertrophy genes transcripts in sickle cell mice","volume":"11","author":"Gbotosho","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1002\/jcp.26799","article-title":"Excessive training induces molecular signs of pathologic cardiac hypertrophy","volume":"233","author":"Teixeira","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"6699054","DOI":"10.1155\/2021\/6699054","article-title":"Alleviation of inflammation and oxidative stress in pressure overload-induced cardiac remodeling and heart failure via IL-6\/STAT3 inhibition by raloxifene","volume":"2021","author":"Huo","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1172\/JCI117956","article-title":"Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture","volume":"95","author":"Palmer","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"e000267","DOI":"10.1161\/JAHA.113.000267","article-title":"Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1\u03b2 upregulation via nuclear factor \u039aB activation","volume":"2","author":"Higashikuni","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.122.060860","article-title":"NLRP3 inflammasome activation through heart-brain interaction initiates cardiac inflammation and hypertrophy during pressure overload","volume":"147","author":"Higashikuni","year":"2023","journal-title":"Circulation"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.RES.81.5.664","article-title":"Increased expression of interleukin-1\u03b2 and monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload","volume":"81","author":"Shioi","year":"1997","journal-title":"Circ. Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"H176","DOI":"10.1152\/ajpheart.00269.2005","article-title":"Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1","volume":"291","author":"Nishikawa","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","article-title":"Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways","volume":"105","author":"Honsho","year":"2009","journal-title":"Circ. Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-\u03921 Mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1038\/s41467-022-30630-y","article-title":"Cardiac fibroblasts regulate the development of heart failure via htra3-TGF-\u03b2-IGFBP7 axis","volume":"13","author":"Ko","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-b1 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"155376","DOI":"10.1016\/j.cyto.2020.155376","article-title":"Wnt3a upregulation is involved in TGF\u03b21-induced cardiac hypertrophy","volume":"138","author":"Li","year":"2021","journal-title":"Cytokine"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"588347","DOI":"10.3389\/fcvm.2020.588347","article-title":"Pivotal role of TGF-\u03b2\/Smad signaling in cardiac fibrosis: Non-coding RNAs as effectual players","volume":"7","author":"Saadat","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac Fibrosis\u2014A short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"C1799","DOI":"10.1152\/ajpcell.00166.2006","article-title":"Cardiac fibroblasts influence cardiomyocyte phenotype in vitro","volume":"292","author":"LaFramboise","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/jmcc.1996.0068","article-title":"Adenovirus-mediated overexpression of human transforming growth factor-\u03b21 in rat cardiac fibroblasts, myocytes and smooth muscle cells","volume":"28","author":"Villarreal","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0022-2828(95)91479-X","article-title":"TGF-\u03b2 Modulates the synthesis of proteoglycans by myocardial fibroblasts in culture","volume":"27","author":"Heimer","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0002-9440(10)63764-9","article-title":"Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-\u03b2 and interleukin-1","volume":"164","author":"Shephard","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Geinoz","year":"1993","journal-title":"J. Cell Biol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1073\/pnas.88.3.795","article-title":"Cardiac fibroblasts are predisposed to convert into myocyte phenotype: Specific effect of transforming growth factor beta","volume":"88","author":"Eghbali","year":"1991","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"e010013","DOI":"10.1161\/JAHA.118.010013","article-title":"Cardiac fibrosis in proteotoxic cardiac disease is dependent upon myofibroblast TGF-\u03b2 signaling","volume":"7","author":"Bhandary","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/cvr\/cvz187","article-title":"ADAMTS16 activates latent TGF-\u03b2, accentuating fibrosis and dysfunction of the pressure-overloaded heart","volume":"116","author":"Yao","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Dzia\u0142o, E., Czepiel, M., Tkacz, K., Siedlar, M., Kania, G., and B\u0142yszczuk, P. (2021). WNT\/\u03b2-catenin signaling promotes TGF-\u03b2-mediated activation of human cardiac fibroblasts by enhancing IL-11 production. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810072"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00418-008-0541-5","article-title":"Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload","volume":"131","author":"Xia","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-\u03b2 function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1111\/jcmm.17478","article-title":"Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-\u03b21\/Smad3 signalling pathway","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"E841","DOI":"10.1073\/pnas.1202081109","article-title":"Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-\u03b2 signaling","volume":"109","author":"Wei","year":"2012","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.86.12.1259","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1 decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro","volume":"86","author":"Siwik","year":"2000","journal-title":"Circ. Res."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2007.08.003","article-title":"Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts","volume":"362","author":"Brown","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"39513","DOI":"10.1074\/jbc.M405844200","article-title":"Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1\u03b2","volume":"279","author":"Xie","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"25796","DOI":"10.1074\/jbc.273.40.25796","article-title":"Cardiac fibroblasts arrest at the G1\/S restriction point in response to interleukin (IL)-1\u03b2. evidence for IL-1beta-induced hypophosphorylation of the retinoblastoma protein","volume":"273","author":"Koudssi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"H1968","DOI":"10.1152\/ajpheart.1999.276.6.H1968","article-title":"Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts","volume":"276","author":"Yokoyama","year":"1999","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12265-017-9775-8","article-title":"The interleukin-33\/st2 pathway is expressed in the failing human heart and associated with pro-fibrotic remodeling of the myocardium","volume":"11","author":"Tseng","year":"2018","journal-title":"J. Cardiovasc. Transl."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/cvr\/cvab205","article-title":"Loss of yap\/taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function","volume":"118","author":"Mia","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2017.04.022","article-title":"Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress","volume":"138","author":"Veeraveedu","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvs142","article-title":"A pro-fibrotic role for interleukin-4 in cardiac pressure overload","volume":"95","author":"Kanellakis","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"790511","DOI":"10.3389\/fimmu.2021.790511","article-title":"MAP kinase phosphatase-5 deficiency protects against pressure overload-induced cardiac fibrosis","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","article-title":"IL-17 Stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1\/2-dependent C\/EBP-\u03b2, NF-\u039aB, and AP-1 activation","volume":"293","author":"Cortez","year":"2007","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yexmp.2009.06.001","article-title":"IL-17 induces myocardial fibrosis and enhances RANKL\/OPG and MMP\/TIMP signaling in isoproterenol-induced heart failure","volume":"87","author":"Feng","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","article-title":"Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats","volume":"56","author":"McLarty","year":"2010","journal-title":"Hypertension"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cvr\/cvy013","article-title":"IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis","volume":"114","author":"Chou","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"F654","DOI":"10.1152\/ajprenal.00396.2021","article-title":"Interleukin-6 blockade reduces salt-induced cardiac inflammation and fibrosis in subtotal nephrectomized mice","volume":"323","author":"Tanaka","year":"2022","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","article-title":"Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling","volume":"181","author":"Zhang","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"H1694","DOI":"10.1152\/ajpheart.00908.2008","article-title":"IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart","volume":"296","author":"Banerjee","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_290","first-page":"12","article-title":"Programmed cell death and its role in inflammation","volume":"2","author":"Yang","year":"2015","journal-title":"Mil. Med. Res."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456","article-title":"The inflammatory response to cell death","volume":"3","author":"Rock","year":"2008","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1073\/pnas.070036297","article-title":"Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction","volume":"97","author":"Kurrelmeyer","year":"2000","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.CIR.97.14.1375","article-title":"Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-\u03b1","volume":"97","author":"Bryant","year":"1998","journal-title":"Circulation"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/modpathol.3800568","article-title":"Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction","volume":"19","author":"Akasaka","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004240100612","article-title":"Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo","volume":"442","author":"Patten","year":"2001","journal-title":"Pfl\u00fcgers Arch."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/eurjhf\/hfr079","article-title":"Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?","volume":"13","author":"Collier","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/AC.69.4.3036655","article-title":"Inflammatory mediators in chronic heart failure in north india","volume":"69","author":"Fedacko","year":"2014","journal-title":"Acta Cardiol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"e023582","DOI":"10.1161\/JAHA.121.023582","article-title":"Neuromodulation of inflammation to treat heart failure with preserved ejection fraction: A pilot randomized clinical trial","volume":"11","author":"Stavrakis","year":"2021","journal-title":"J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"ref_299","first-page":"172","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehp454","article-title":"Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: Insights from the multi-ethnic study of atherosclerosis","volume":"31","author":"Yan","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00380-004-0770-z","article-title":"Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure","volume":"19","author":"Hirota","year":"2004","journal-title":"Heart Vessel."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)","volume":"27","author":"Kapadia","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1388-9842(01)00137-4","article-title":"Activation of the cardiac interleukin-6 system in advanced heart failure","volume":"3","author":"Gabriele","year":"2001","journal-title":"Eur. J. Heart Fail."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCULATIONAHA.109.933127","article-title":"Continuous glycoprotein-130\u2013mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction","volume":"122","author":"Shukla","year":"2010","journal-title":"Circulation"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cyto.2018.07.037","article-title":"NT-ProBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure","volume":"111","author":"Stanciu","year":"2018","journal-title":"Cytokine"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCHEARTFAILURE.112.972653","article-title":"Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure","volume":"6","author":"Askevold","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cardfail.2021.01.006","article-title":"Interleukin-6 and outcomes in acute heart failure: An ASCEND-HF substudy","volume":"27","author":"Perez","year":"2021","journal-title":"J. Card. Fail."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0735-1097(01)01795-8","article-title":"Physical training modulates proinflammatory cytokines and the soluble fas\/soluble fasligand system in patients with chronic heart failure","volume":"39","author":"Adamopoulos","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/2047487317690458","article-title":"Inflammatory biomarkers and effect of exercise on functional capacity in patients with heart failure: Insights from a randomized clinical trial","volume":"24","author":"Rigaud","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/oxfordjournals.eurheartj.a015268","article-title":"Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure","volume":"18","author":"Devaux","year":"1997","journal-title":"Eur. Heart J."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.CIR.101.21.2518","article-title":"Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy","volume":"101","author":"Kubota","year":"2000","journal-title":"Circulation"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1161\/CIRCULATIONAHA.106.633180","article-title":"Cardiac improvement during mechanical circulatory support","volume":"115","author":"Maybaum","year":"2007","journal-title":"Circulation"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.0000120704.97934.41","article-title":"Elevated levels of activin a in heart failure","volume":"109","author":"Yndestad","year":"2004","journal-title":"Circulation"},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00392-010-0248-1","article-title":"Transforming growth factor beta 1 (TGF-Beta 1) in atrial fibrillation and acute congestive heart failure","volume":"100","author":"Behnes","year":"2011","journal-title":"Clin. Res. Cardiol."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00424-002-0921-y","article-title":"Chronic exposure to interleukin 1\u03b2 induces a delayed and reversible alteration in excitation\u2013contraction coupling of cultured cardiomyocytes","volume":"445","author":"Combes","year":"2002","journal-title":"Pfl\u00fcgers Arch."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"H141","DOI":"10.1152\/ajpheart.1999.276.1.H141","article-title":"Suppression of \u03b2-Adrenergic responsiveness of L-type Ca2+ current by IL-1\u03b2 in rat ventricular myocytes","volume":"276","author":"Liu","year":"1999","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"H1025","DOI":"10.1152\/ajpheart.00795.2013","article-title":"Interleukin-18 mediates interleukin-1-induced cardiac dysfunction","volume":"306","author":"Toldo","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1096\/fj.04-2426fje","article-title":"Evidence for altered interleukin (IL)-18 pathway in human heart failure","volume":"18","author":"Mallat","year":"2004","journal-title":"FASEB J."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/heart.88.3.296","article-title":"Increased circulating interleukin-18 in patients with congestive heart failure","volume":"88","author":"Naito","year":"2002","journal-title":"Heart"},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"e004373","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373","article-title":"Interleukin-1 blockade in recently decompensated systolic heart failure","volume":"10","author":"Tassell","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"e005036","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 Blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Tassell","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ehj.2003.09.023","article-title":"Association of lipoproteins with cytokines and cytokine receptors in heart failure patients differences between ischaemic versus idiopathic cardiomyopathy","volume":"24","author":"Conraads","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"epidemiology of atrial fibrillation in the 21st century","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ. Res."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2018.10.020","article-title":"Role of inflammatory signaling in atrial fibrillation","volume":"287","author":"Scott","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1253\/circj.CJ-15-0138","article-title":"Role of inflammation in atrial fibrillation pathophysiology and management","volume":"79","author":"Harada","year":"2015","journal-title":"Circ. J."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"758157","DOI":"10.3389\/fimmu.2021.758157","article-title":"Interleukin-6-mediated-Ca2+ handling abnormalities contributes to atrial fibrillation in sterile pericarditis rats","volume":"12","author":"Liao","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.hrthm.2018.06.025","article-title":"Association of fibrotic remodeling and cytokines\/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation","volume":"15","author":"Abe","year":"2018","journal-title":"Heart Rhythm."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2013.08.078","article-title":"Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis","volume":"169","author":"Wu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2007.09.006","article-title":"Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the heart and soul study","volume":"155","author":"Marcus","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2017.12.026","article-title":"The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation","volume":"103","author":"Stanciu","year":"2018","journal-title":"Cytokine"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.hrthm.2009.12.009","article-title":"Role of inflammation and oxidative stress in atrial fibrillation","volume":"7","author":"Li","year":"2010","journal-title":"Heart Rhythm."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.hrthm.2009.10.004","article-title":"Intracardiac and extracardiac markers of inflammation during atrial fibrillation","volume":"7","author":"Marcus","year":"2010","journal-title":"Heart Rhythm."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/europace\/eur402","article-title":"Role of inflammation in early atrial fibrillation recurrence","volume":"14","author":"Smit","year":"2012","journal-title":"Europace"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.hlc.2014.02.003","article-title":"Serum inflammation markers predicting successful initial catheter ablation for atrial fibrillation","volume":"23","author":"Kimura","year":"2014","journal-title":"Heart Lung Circ."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/CS20080372","article-title":"Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF)","volume":"116","author":"Pinto","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2012.04812.x","article-title":"High sensitivity cardiac troponin t and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation","volume":"10","author":"Gallego","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hrthm.2007.10.007","article-title":"Markers of inflammation before and after curative ablation of atrial flutter","volume":"5","author":"Marcus","year":"2008","journal-title":"Heart Rhythm."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.hrthm.2017.09.039","article-title":"Sympathetic nerve blocks promote anti-inflammatory response by activating the JAK2-STAT3\u2013mediated signaling cascade in rat myocarditis models: A novel mechanism with clinical implications","volume":"15","author":"Park","year":"2018","journal-title":"Heart Rhythm."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/ki.2008.449","article-title":"The Association of sudden cardiac death with inflammation and other traditional risk factors","volume":"74","author":"Parekh","year":"2008","journal-title":"Kidney Int."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/ATVBAHA.110.208785","article-title":"C-Reactive protein, interleukin 6, fibrinogen and risk of sudden death in european middle-aged men: The PRIME study","volume":"30","author":"Empana","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5604\/17322693.1194612","article-title":"Inflammation markers are associated with metabolic syndrome and ventricular arrhythmia in patients with coronary artery disease","volume":"70","author":"Safranow","year":"2016","journal-title":"Post\u0119py Hig. Med. Do\u015bwiadczalnej"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2007.07.187","article-title":"Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients\u2014A pilot study","volume":"40","author":"Streitner","year":"2007","journal-title":"Cytokine"},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1093\/eurheartj\/ehp316","article-title":"Interleukin 18 gene promoter polymorphism: A link between hypertension and pre-hospital sudden cardiac death: The helsinki sudden death study","volume":"30","author":"Hernesniemi","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2004.09.024","article-title":"Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes","volume":"503","author":"Salameh","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_345","first-page":"647","article-title":"Proinflammatory cytokines (IL-6, TNF-Alpha) and cardiac troponin I (CTnI) in serum of young people with ventricular arrhythmias","volume":"108","author":"Kowalewski","year":"2002","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"H790","DOI":"10.1152\/ajpheart.00498.2011","article-title":"Myofibroblasts cause heterogeneous cx43 reduction and are unlikely to be coupled to myocytes in the healing canine infarct","volume":"302","author":"Baum","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_347","doi-asserted-by":"crossref","unstructured":"Kaur, K., Zarzoso, M., Ponce-Balbuena, D., Guerrero-Serna, G., Hou, L., Musa, H., and Jalife, J. (2013). TGF-\u03921, Released by myofibroblasts, differentially regulates transcription and function of sodium and potassium channels in adult rat ventricular myocytes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055391"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet"},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.carpath.2015.07.006","article-title":"Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease","volume":"24","author":"Wen","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"ref_350","first-page":"251","article-title":"Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class","volume":"14","author":"Davutoglu","year":"2005","journal-title":"J. Heart Valve Dis."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000088104","article-title":"Balance between plasma levels of tumor necrosis factor-\u03b1 and interleukin-10 in rheumatic mitral stenosis","volume":"104","author":"Chen","year":"2005","journal-title":"Cardiology"},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s004310050545","article-title":"Cytokines in acute rheumatic fever","volume":"156","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijcard.2019.04.063","article-title":"Circulating cytokines predict severity of rheumatic heart disease","volume":"289","author":"Soares","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/03009749509095185","article-title":"Plasma Interleukin-7 (IL-7) and IL-8 Concentrations in acute rheumatic fever and chronic rheumatic heart disease","volume":"24","author":"Narin","year":"1995","journal-title":"Scand. J. Rheumatol."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/clin.1995.1140","article-title":"Lymphocyte subsets and plasma IL-1 \u03b1, IL-2, and TNF-\u03b1 concentrations in acute rheumatic fever and chronic rheumatic heart disease","volume":"77","author":"Narin","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1017\/S1047951114001012","article-title":"Plasma adiponectin levels and relations with cytokines in children with acute rheumatic fever","volume":"25","author":"Ozgen","year":"2015","journal-title":"Cardiol. Young"},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"155370","DOI":"10.1016\/j.cyto.2020.155370","article-title":"Cytokine gene functional polymorphisms and phenotypic expression as predictors of evolution from latent to clinical rheumatic heart disease","volume":"138","author":"Tormin","year":"2021","journal-title":"Cytokine"},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","article-title":"Rheumatic heart disease proinflammatory cytokines play a role in the progression and maintenance of valvular lesions","volume":"165","author":"Guilherme","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"604826","DOI":"10.3389\/fcvm.2020.604826","article-title":"Decreased cytokine plasma levels and changes in t-cell activation are associated with hemodynamic improvement and clinical outcomes after percutaneous mitral commissurotomy in patients with rheumatic mitral stenosis","volume":"7","author":"Silva","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<105::AID-PATH1094>3.0.CO;2-E","article-title":"Expression of cytokine mrnas in murine hearts with acute myocarditis caused by coxsackievirus B3","volume":"183","author":"Seko","year":"1997","journal-title":"J. Pathol."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1161\/01.CIR.94.11.2930","article-title":"Persistent expression of cytokine in the chronic stage of viral myocarditis in mice","volume":"94","author":"Shioi","year":"1996","journal-title":"Circulation"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.4049\/jimmunol.167.9.5464","article-title":"Dual role of the IL-12\/IFN-\u03b3 axis in the development of autoimmune myocarditis: Induction by IL-12 and protection by IFN-\u03b3","volume":"167","author":"Eriksson","year":"2001","journal-title":"J. Immunol."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.CIR.103.1.18","article-title":"Lethal Autoimmune myocarditis in interferon-\u03b3 receptor\u2013deficient mice","volume":"103","author":"Eriksson","year":"2001","journal-title":"Circulation"},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4049\/jimmunol.151.3.1682","article-title":"Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis","volume":"151","author":"Lane","year":"1993","journal-title":"J. Immunol."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0006-291X(91)91219-3","article-title":"Detection of Interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction","volume":"181","author":"Han","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/hrt.72.6.561","article-title":"Increased circulating cytokines in patients with myocarditis and cardiomyopathy","volume":"72","author":"Matsumori","year":"1994","journal-title":"Br. Heart J."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cei.13314","article-title":"IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of kawasaki disease vasculitis and myocarditis","volume":"198","author":"Gorelik","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/1756-185X.13029","article-title":"Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant","volume":"20","author":"Mitjavila","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: The AIRTRIP Randomized clinical trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ehjcvp\/pvx018","article-title":"Interleukin-1 blockade for the treatment of pericarditis","volume":"4","author":"Buckley","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis","volume":"384","author":"Klein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires TGF-\u03b2","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/jcb.24058","article-title":"TGF\u03b2-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy","volume":"113","author":"Bos","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.96.3.874","article-title":"Overexpression of transforming growth factor-\u03b21 and insulin-like growth factor-i in patients with idiopathic hypertrophic cardiomyopathy","volume":"96","author":"Li","year":"1997","journal-title":"Circulation"},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mtc.2002.118275","article-title":"Regional overexpression of insulin-like growth factor-i and transforming growth factor-\u03b21 in the myocardium of patients with hypertrophic obstructive cardiomyopathy","volume":"123","author":"Li","year":"2002","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_377","first-page":"II144","article-title":"Elevated insulin-like growth factor-i and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. a possible mechanism","volume":"98","author":"Li","year":"1998","journal-title":"Circulation"},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/clc.22404","article-title":"Increased transforming growth factor-\u03b2 levels associated with cardiac adverse events in hypertrophic cardiomyopathy","volume":"38","author":"Sahin","year":"2015","journal-title":"Clin. Cardiol."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1161\/01.CIR.103.14.1844","article-title":"Decreased expression of tumor necrosis factor-\u03b1 and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy","volume":"103","author":"Nagueh","year":"2001","journal-title":"Circulation"},{"key":"ref_380","first-page":"150","article-title":"cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origins","volume":"68","author":"Talha","year":"2001","journal-title":"Pathobiology"},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/heartjnl-2011-300960","article-title":"Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"98","author":"Kuusisto","year":"2012","journal-title":"Heart"},{"key":"ref_382","first-page":"53","article-title":"Comparative study of the roles of cytokines and apoptosis in dilated and hypertrophic cardiomyopathies","volume":"15","author":"Megyeri","year":"2004","journal-title":"Eur. Cytokine Netw."},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1536\/ihj.46.231","article-title":"Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy","volume":"46","author":"Zen","year":"2005","journal-title":"Int. Heart J."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2021.09.009","article-title":"Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy","volume":"344","author":"Hassoun","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_385","first-page":"100","article-title":"Diabetic cardiomyopathy","volume":"222","author":"Lorenzo","year":"2022","journal-title":"Rev. Cl\u00ednica Espa\u00f1ola Engl. Ed."},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2016.02.111","article-title":"Toll-like receptor-6 (TLR6) deficient mice are protected from myocardial fibrosis induced by high fructose feeding through anti-oxidant and inflammatory signaling pathway","volume":"473","author":"Zhang","year":"2016","journal-title":"Biochem. Bioph Res. Commun."},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1074\/jbc.M114.550624","article-title":"Mitochondrial NLRP3 protein induces reactive oxygen species to promote smad protein signaling and fibrosis independent from the inflammasome*","volume":"289","author":"Bracey","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1159\/000481843","article-title":"H3 relaxin protects against myocardial injury in experimental diabetic cardiomyopathy by inhibiting myocardial apoptosis, fibrosis and Inflammation","volume":"43","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00395-019-0771-9","article-title":"Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart","volume":"115","author":"Fender","year":"2020","journal-title":"Basic. Res. Cardiol."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/tox.22882","article-title":"Deep sea minerals ameliorate diabetic-induced inflammation via inhibition of TNF\u03b1 signaling pathways","volume":"35","author":"Lu","year":"2020","journal-title":"Environ. Toxicol."},{"key":"ref_391","doi-asserted-by":"crossref","unstructured":"Yu, X.-Y., Chen, H.-M., Liang, J.-L., Lin, Q.-X., Tan, H.-H., Fu, Y.-H., Liu, X.-Y., Shan, Z.-X., Li, X.-H., and Yang, H.-Z. (2011). Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: Macrophage migration inhibitory factor. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016239"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1082\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:47:44Z","timestamp":1760104064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":391,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25021082"],"URL":"https:\/\/doi.org\/10.3390\/ijms25021082","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]}}}